Raymond James & Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,776
| Closed | -$228K | – | 4052 |
|
|
2022
Q1 | $228K | Buy |
2,776
+73
| +3% | +$6K | ﹤0.01% | 3562 |
|
|
2021
Q4 | $397K | Sell |
2,703
-1,234
| -31% | -$181K | ﹤0.01% | 3245 |
|
|
2021
Q3 | $696K | Buy |
3,937
+2,327
| +145% | +$411K | ﹤0.01% | 2813 |
|
|
2021
Q2 | $260K | Sell |
1,610
-4,748
| -75% | -$767K | ﹤0.01% | 3503 |
|
|
2021
Q1 | $1.09M | Buy |
6,358
+210
| +3% | +$36K | ﹤0.01% | 2448 |
|
|
2020
Q4 | $1.35M | Sell |
6,148
-93
| -1% | -$20.4K | ﹤0.01% | 2130 |
|
|
2020
Q3 | $1.04M | Buy |
6,241
+1,694
| +37% | +$281K | ﹤0.01% | 2152 |
|
|
2020
Q2 | $519K | Buy |
4,547
+110
| +2% | +$12.6K | ﹤0.01% | 2546 |
|
|
2020
Q1 | $341K | Sell |
4,437
-653
| -13% | -$50.2K | ﹤0.01% | 2679 |
|
|
2019
Q4 | $656K | Buy |
+5,090
| New | +$656K | ﹤0.01% | 2528 |
|
|
2019
Q3 | – | Sell |
-2,043
| Closed | -$210K | – | 3590 |
|
|
2019
Q2 | $210K | Buy |
+2,043
| New | +$210K | ﹤0.01% | 3201 |
|